TransMedics Group, Inc. (TMDX)

TransMedics Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4,907	2,577	1,970	532	541	393
Market Cap Growth	-0.79%	30.78%	270.34%	-1.57%	37.38%	-
Enterprise Value	5,072	2,698	1,836	483	449	346
PE Ratio	-	-102.96	-54.38	-12.03	-18.80	-11.73
PS Ratio	16.53	10.67	21.08	17.58	21.08	16.67
PB Ratio	30.77	18.78	10.52	7.84	5.20	7.20
P/FCF Ratio	-11.92	-15.63	-34.13	-16.43	-17.59	-12.12
P/OCF Ratio	-310.04	-197.80	-43.01	-18.43	-17.86	-12.19
EV/Sales Ratio	17.08	11.16	19.65	15.96	17.51	14.68
EV/EBITDA Ratio	362.09	-404.91	-65.01	-12.82	-19.39	-12.40
EV/EBIT Ratio	3083.39	-169.87	-56.61	-11.98	-18.16	-11.88
EV/FCF Ratio	-12.74	-16.36	-31.81	-14.91	-14.62	-10.67
Debt / Equity Ratio	3.24	3.76	0.36	0.65	0.33	0.62
Debt / EBITDA Ratio	36.85	-77.45	-2.39	-1.16	-1.50	-1.22
Debt / FCF Ratio	-2.54	-3.13	-1.17	-1.35	-1.13	-1.05
Quick Ratio	8.61	8.35	9.69	4.26	11.20	5.45
Current Ratio	9.72	9.30	10.66	5.11	12.36	6.21
Asset Turnover	0.42	0.41	0.47	0.22	0.18	0.25
Interest Coverage	0.12	-1.47	-8.71	-10.40	-6.21	-6.70
Return on Equity (ROE)	-7.20%	-16.60%	-29.80%	-53.10%	-30.80%	1375.40%
Return on Assets (ROA)	-1.50%	-4.20%	-18.30%	-32.00%	-20.10%	-35.50%
Return on Capital (ROIC)	-2.10%	-4.40%	-12.33%	-35.31%	-19.04%	-33.34%
Earnings Yield	-0.21%	-0.97%	-1.84%	-8.31%	-5.32%	-8.53%
FCF Yield	-4.14%	-6.40%	-2.93%	-6.09%	-5.68%	-8.25%
Buyback Yield / Dilution	-7.50%	-10.02%	-7.02%	-11.80%	-73.90%	-945.47%
Total Shareholder Return	-7.50%	-10.02%	-7.02%	-11.80%	-73.90%	-945.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).